Interoperability
HEALTH POLICY BRIEF — Thursday, September 24
ONC owns today’s clock. Its USCDI Version 8 input window closes Monday, September 28, at 11:59 p.m.
Latest
Briefing
FDA Rewrites Its Rulebook to Make Room Beyond Animal Tests
FDA has paired a direct final rule with a companion proposal to replace animal-centered language across its human drug and biologic regulations with the…
Interoperability
HEALTH POLICY BRIEF — Wednesday, September 23
The live stakes are a five-day standards window, an immediate Marketplace fraud rule, and a chance to test whether electronic prior authorization is truly…
Physician Payment
VA Is Splitting One Reimbursement Form Into Two for Veterans’ Drug, Medical, and Transportation Claims
The Department of Veterans Affairs plans to retire a single catch-all reimbursement form and replace it with two forms—one for prescription drugs and…
Briefing
HEALTH POLICY BRIEF — Tuesday, September 22
CMS has put the 2027 laboratory fee schedule into the comment lane—and the preliminary math is steep.
Interoperability
HEALTH POLICY BRIEF — Monday, September 21
Three federal policy windows are now on the clock: Medicaid drug pricing, the next generation of interoperability data, and standards for medical imaging…
Interoperability
HEALTH POLICY BRIEF — Friday, September 18
CMS is scaling technology-supported chronic care, and the physician-integration questions are no longer theoretical.
AI Governance
HEALTH POLICY BRIEF — Thursday, September 17
WISeR’s burden-reduction promise has collided with its implementation record.
Interoperability
HEALTH POLICY BRIEF — Wednesday, September 16
CMS is widening its bet on technology-supported chronic care—and the implementation burden is about to get real.
AI Governance
HEALTH POLICY BRIEF — Tuesday, September 15
WISeR’s paperwork problem has moved from theory to evidence.
Privacy and Security
HEALTH POLICY BRIEF — Monday, September 14
ONC has published USCDI Version 7, adding 31 data elements and expanding the federal vocabulary around patient safety, nutrition care, and other clinical…
AI Governance
FDA codifies a Class II pathway for certain cardiovascular machine-learning notification software
FDA has finalized a device classification that gives a defined regulatory home to a narrow category of cardiovascular machine-learning software.